Renjun Gu

Renjun Gu


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Epilepsy & Behavior
Verified
Journal Article
Closed access
SYShijun Yang
Shijun Yang
XHXiong Han
Xiong Han
NWNa Wang
Na Wang
RGRenjun Gu
Renjun Gu
WCWenwu Chen
Wenwu Chen
YCYanan Chen
Yanan Chen

3 January 2022 in Brain Research Bulletin
Verified
Journal Article
Closed access
LXLinlin Xu
Linlin Xu
XLXuejiao Liu
Xuejiao Liu
CGChao Guo
Chao Guo
CWChan Wang
Chan Wang
JZJing Zhao
Jing Zhao
RGRenjun Gu
Renjun Gu

5 December 2022 in NeuroToxicology
Verified
Journal Article
Closed access
FZFan Zhang
Fan Zhang
JZJiao Zeng
Jiao Zeng
XZXiaoli Zhang
Xiaoli Zhang
JGJiapeng Gu
Jiapeng Gu
YHYongkai Han
Yongkai Han
RGRenjun Gu
Renjun Gu

14 October 2020 in Behavioural Neurology
Verified
Journal Article
Open access
PDF file
LXLinlin Xu
Linlin Xu
XLXuejiao Liu
Xuejiao Liu
JZJing Zhao
Jing Zhao
JZJiao Zeng
Jiao Zeng
JGJiapeng Gu
Jiapeng Gu
RGRenjun Gu
Renjun Gu
Objective. The aim of this study is to explore the relationship between neuron-specific enolase (NSE) gene polymorphism and delayed encephalopathy after acute carbon monoxide poisoning (DEACMP) and provide a theoretical basis for DEACMP pathogenesis, diagnosis, and prognosis. Methods. To investigate this relationship, we screened 6 NSE single nucleotide polymorphisms (SNPs), based on the results of the previous genome-wide association studies (GWAS). A total of 1,201 patients, including 416 in the DEACMP group and 785 in the acute carbon monoxide poisoning (ACMP) group, were detected by the Sequenom MassARRAY® method. The genotype frequencies and alleles of the 6 NSE SNPs (rs2071074, rs2071417, rs2071419, rs11064464, rs11064465, and rs3213434) were compared using different genetic models. Results. In the SNPs rs2071419 and rs3213434, we found that the genotypes and allele frequencies in the two groups significantly correlated with the grouping of patients ( , ; , ). The haplotypes GGTTTC and CCTTTC of ACMP and DEACMP were different ( , ; , ). We also observed that rs2071419 and rs3213434 significantly correlated with DEACMP-increased risk in the dominant, codominant, and overdominant genetic models. In addition, we speculated that the C allele of the rs2071419 polymorphism and the T allele of the rs3213434 polymorphism in NSE may increase the DEACMP risk ( , ). Conclusions. The results show that rs2071419 and rs3213434 are susceptible sites of DEACMP. The NSE C allele of rs2071419 and T allele of rs3213434 and the haplotypes GGTTTC and CCTTTC may be risk factors for DEACMP.

1 January 2023 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
PDF file
XZXiaoli Zhang
Xiaoli Zhang
JZJiao Zeng
Jiao Zeng
XGXin Gu
Xin Gu
FZFan Zhang
Fan Zhang
YHYongkai Han
Yongkai Han
RGRenjun Gu
Renjun Gu
Background and Study Aims: Antiepileptic drugs are the first choice of treatment for patients with epilepsy. However, the withdrawal of antiepileptic drugs after seizure-free remains a significant focus for the majority of patients with epilepsy and their families. In this study, we evaluated the risk factors associated with relapse after drug withdrawal in patients with seizure free for 2 years. We aimed to guide patients in seizure-free to assess the risk of drug withdrawal. Patients and Methods: Through screening, 452 patients with epilepsy were included in the study.Patients were followed up for at least 2 years or more. Analyzed their clinical data by applying the χ 2-test, Kaplan-Meier survival analysis and multivariate Cox regression analysis. Results: 423 patients completed follow-up, of which 304 cases recurred (71.9%).Related recurrence factors include age of onset, type of seizure, number of AEDs, seizure-free time before withdrawal, and electroencephalogram (EEG) results before drug withdrawal (P< 0.05). The results of correlation analysis showed that age of onset, seizure frequency, seizure type, number of AEDs, the period from AEDs treatment to a seizure-free status, EEG results before drug withdrawal, and pre-medication course, were all significantly related to the recurrence of seizures after drug reduction and withdrawal (P< 0.05). We identified a range of independent risk factors, including onset age, seizure frequency, Multiple AEDs and the period from AEDs treatment to a seizure-free status. Conclusion: The overall recurrence rate of epilepsy in our patient cohort was high, and the peak recurrence period was within one-year of drug withdrawal. Patients with partial seizures, a short seizure-free time before withdrawal, severe EEG abnormalities before drug reduction, and a long course of the disease, are prone to relapse. Patients with an older age at onset and a high frequency of attack, those taking multi-drug combination therapy, and those that take a long time to gain control, should be managed carefully to AEDs withdrawal.

16 December 2019 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
JGJiapeng Gu
Jiapeng Gu
JZJiao Zeng
Jiao Zeng
XWXi Wang
Xi Wang
XGXin Gu
Xin Gu
XZXiaoli Zhang
Xiaoli Zhang
RGRenjun Gu
Renjun Gu
Background: We explored the association of leucine-rich repeats and calponin homology domain containing 1 (LRCH1) gene polymorphisms with genetic susceptibility to delayed encephalopathy after acute carbon monoxide poisoning (DEACMP), which might provide a theoretical basis for the pathogenesis, diagnosis, and prognosis research of DEACMP. Methods: Four single nucleotide polymorphisms, rs1539177 (G/A), rs17068697 (G/A), rs9534475 (A/C), and rs2236592 (T/C), of LRCH1, selected as candidate genes through genome-wide association analysis, were genotyped in 661 patients (DEACMP group: 235 cases; ACMP group: 426 cases) using Sequenom Massarray®. The association analysis of four SNPs and LRCH1 was performed under different genetic models. Results: LRCH1 polymorphisms (rs1539177, rs17068697, rs9534475) under additive and dominant genetic models were significantly associated with an increased risk of DEACMP, but no significant association under allele and recessive models was found. The LRCH1 rs2236592 polymorphism was susceptible to DEACMP only under the dominant model (TT/TC + CC, OR = 1.616, 95% CI: 1.092–2.390, P = 0.015784). In addition, the A allele gene of rs9534475 polymorphism in LRCH1 might increase the risk for DEACMP (OR = 1.273, 95% CI: 1.013–1.601, P = 0.038445). Conclusions: We found a significant association between the four LRCH1 polymorphisms and DEACMP. The allelic A of rs9534475 polymorphism in LRCH1 might be a risk factor for DEACMP.